Furthermore, the p‐STAT3 level was significantly different in tumour size and lymph node metastasis, rather than other clinical characteristics, including age, sex, tumour node metastasis stage and recurrence risk stratification. The gene discussed is STAT3; the disease is metastatic malignant neoplasm in the lymph nodes.